Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Allan R. Camrud"'
Autor:
Peter B. Berger, Charles J. McKenna, Allan R. Camrud, David R. Holmes, Robert S. Schwartz, Stephanie H. Wilson
Publikováno v:
Catheterization and Cardiovascular Diagnosis. 45:332-336
In-stent restenosis remains a clinical therapeutic challenge. Rotational atherectomy (RA) is an attractive treatment option as it may cause less vascular injury than balloon angioplasty (BA) and, therefore, limit further neointimal response. In an an
Autor:
Michael E. Staab, Myung Ho Jeong, David R. Holmes, Sanjay S. Srivatsa, Daniel K. Meeker, Jean Grégoire, William D. Edwards, Robert S. Schwartz, Allan R. Camrud, Michael A. Jorgenson, Ladonna J. Camrud
Publikováno v:
Journal of Interventional Cardiology. 10:61-69
Severe, chronic, and nonfatal stenoses in coronary arteries have been dificult to induce consistently in large animals. Availability of such a model would have practical applications, including understanding the pathophysiology of coronary stenoses a
Autor:
Jean Grégoire, Robert S. Schwartz, Allan R. Camrud, Amir Lerman, Kent R. Bailey, Robert A. Van Tassel, Myung Ho Jeong, William D. Edwards, David R. Holmes
Publikováno v:
Lasers in Surgery and Medicine. 21:374-383
Background and Objective Smooth muscle cell migration and proliferation from arterial media into the neointima are major factors in the restenosis process following coronary angioplasty. Because short wave ultraviolet (UV) radiation is cytotoxic for
Autor:
David R. Holmes, John P. Veinot, Robert G. Johnson, Michael A. Jorgenson, Daniel J. Holder, Robert S. Schwartz, Allan R. Camrud
Publikováno v:
Circulation. 93:1542-1548
Background Fibrin- and platelet-rich thrombus formations occur as the initial event after percutaneous transluminal coronary angioplasty. We therefore tested the hypothesis that short-term administration of the recombinant tick anticoagulant peptide
Autor:
Robert S. Schwartz, Allan R. Camrud, David R. Holmes, Michael A. Jorgenson, Kent R. Bailey, William D. Edwards
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 14:395-400
Neointimal hyperplasia occurs in the coronary arteries after percutaneous revascularization procedures and is a reparative response that frequently causes recurrent stenosis. Prior animal studies have shown that neointimal tissue thickness is proport
Autor:
Ronald E. Vlietstra, David R. Holmes, Joseph G. Murphy, Allan R. Camrud, R. S. Schwartz, William D. Edwards
Publikováno v:
Circulation. 86:1596-1604
BACKGROUND To test the feasibility of percutaneous deployment of intracoronary polymeric stents, a prototype polyethylene terephthalate (PET) stent and a catheter-based delivery system were developed. METHODS AND RESULTS Polymeric stents were deploye
Autor:
Ronald E. Vlietstra, Robert S. Schwartz, Allan R. Camrud, David R. Holmes, William D. Edwards, Kenneth C. Huber, Joseph G. Murphy
Publikováno v:
Journal of the American College of Cardiology. 19(2):267-274
Restenosis is a reparative response to arterial injury occurring with percutaneous coronary revascularization. However, the quantitative characteristics of the relation between vessel injury and the magnitude of restenotic response remain unknown. Th
Autor:
Giuseppe Sangiorgi, William D. Edwards, Robert S. Schwartz, Allan R. Camrud, Hyuck Moon Kwon, Charles J. McKenna, David R. Holmes
Objectives. This study was designed to test the efficacy and safety of a fibrin-film–covered stent compared with that of a bare metal stent in the porcine coronary injury model. Background. Biodegradable stents are a potential method of achieving t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c7053d987d714ac3e5181ef726967f
http://hdl.handle.net/2108/108310
http://hdl.handle.net/2108/108310
Autor:
Michael A. Jorgenson, David R. Holmes, Kent R. Bailey, Allan R. Camrud, Kenneth C. Huber, William D. Edwards, Robert S. Schwartz
Publikováno v:
American heart journal. 125(3)
To assess the effectiveness of angiotensin converting enzyme inhibition in a proliferative porcine coronary restenosis model, 35 animals received orally administered trandolapril (10 mg) or captopril (200 mg) or no drug (control group) for 6 days bef
Autor:
Allan R. Camrud, Robert S. Schwartz, David R. Holmes, Loizos C. Antoniades, Kent R. Bailey, Michael A. Jorgenson, Kenneth C. Huber, William D. Edwards
Publikováno v:
Mayo Clinic proceedings. 68(1)
Coronary restenosis, a major unresolved problem for percutaneous coronary revascularization procedures, has thus far been resistant to all therapeutic strategies. In part, ineffective treatment or prevention of coronary restenosis may be due to relia